Table 2.
Patient demographics: validation cohort
Coronary artery stenosis | |||||
---|---|---|---|---|---|
Low | MID+ | P value | |||
Mean | S.E.M | Mean | S.E.M | uncorrected | |
N per group | 37 | 43 | |||
Sex (% male) | 62.16% | 51.16% | 0.32 | ||
Age (years) | 62.89 | 1.74 | 67.61 | 1.79 | 0.06 |
Race (% minority) | 16.22% | 9.30% | 0.99 | ||
Hispanic (%) | 5.41% | 2.33% | 0.47 | ||
Height (cm) | 173.54 | 2.12 | 170.39 | 1.57 | 0.23 |
Weight (kg) | 96.11 | 4.69 | 86.59 | 3.25 | 0.09 |
BMI | 32.01 | 1.57 | 29.83 | 1.04 | 0.24 |
SBP | 124.62 | 2.58 | 127.42 | 3.02 | 0.49 |
DBP | 70.19 | 1.67 | 68.58 | 1.40 | 0.46 |
MAP | 88.35 | 1.67 | 88.23 | 1.68 | 0.96 |
HR | 69.68 | 1.95 | 71.00 | 2.17 | 0.66 |
Heart Rate | 69.68 | 1.95 | 71.00 | 2.17 | 0.66 |
EF % | 54.70 | 1.67 | 58.16 | 1.51 | 0.13 |
Dyslipidemia | 43.24% | 65.12% | 0.05* | ||
Hypertension | 67.57% | 67.44% | 0.99 | ||
Diabetes mellitus | 21.62% | 23.26% | 0.86 | ||
Smoking | 5.41% | 11.63% | 0.33 | ||
Aspirin | 48.65% | 76.74% | 0.01* | ||
Creatinine | 0.96 | 0.04 | 0.98 | 0.04 | 0.69 |
%Stenosis | 1.57 | 0.48 | 66.79 | 3.97 | 6.50Eāāā25* |
RNA yield (ng/ul) | 81.36 | 2.34 | 84.54 | 2.15 | 0.32 |
Total RNA/tube (ng) | 7322.59 | 7608.50 |